A Single-Arm Study Evaluating the Effectiveness and Safety of Suzetrigine (SUZ) for Acute Pain After Aesthetic or Reconstructive Surgeries
Completed · Phase 4
Conditions studied: Acute Pain
In brief
The purpose of this study to evaluate the effectiveness, safety, and tolerability of SUZ as part of multimodal therapy (MMT) in treating acute postoperative pain.
Key facts
- Study ID
- NCT06887972
- Run by
- Vertex Pharmaceuticals Incorporated
- People needed
- 100
- Starts
- 2025-03-21
- Expected to finish
- 2025-11-07
- Last updated by the study team
- 2025-12-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Atlanta Center for Medical Research — Atlanta, Georgia, United States
- Beth Israel Deaconess Medical Center - Surgery — Boston, Massachusetts, United States
- HD Research LLC | First Surgical Hospital — Bellaire, Texas, United States
- Memorial Hermann Village — Houston, Texas, United States
- JBR Clinical Research — Salt Lake City, Utah, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.